BR
Barinthus Biotherapeutics plc
BRNS · NASDAQ
$0.74 +5.99% (+$0.04)
1M +22.72%
Market Cap $30.2M
P/E Ratio -
Div. Yield -
ROE 59.18%
Bulios Fair Price
$0.68
8.1% downside
Trenutna cena
$0.74
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BRNS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.53x
PEG N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 32.65%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 59.18%
ROA 50.97%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 5.54x
Int. coverage -796.09x
Debt/Equity 0.18x
Stability
13 /100
Unstable Rev. volatility 1,077.08%
EPS volatility 849.26%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BRNS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
William James Enright
Employees
14
Headquarters
Germantown
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report